Sort
10,766 grants matching “checkpoint inhibitor”
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
$535,778Jianjun Gao · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
$535,778Jianjun Gao · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Effective combination therapy for MTAP-deficient bladder carcinoma by targeting metabolic vulnerability and modulating tumor immune microenvironment
$535,778Jianjun Gao · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Cyclin Dependent Kinases as Epigenetic Therapy Targets
$535,736Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2025 · CA
A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy
$535,708Michael Karin · University Of California, San Diego · R01 · FY2024 · CA
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$535,638Wei R. Chen · University Of Oklahoma · R01 · FY2022 · CA
Escape from CAR T surveillance through lineage plasticity
$535,637Patricia A Ernst · University Of Colorado Denver · R01 · FY2024 · CA
A novel signaling mechanism for LRP5
$535,605Dianqing Wu · Yale University · R01 · FY2023 · CA
Regulation of Mitotic Kinetochores by the Ran GTPase
$535,580Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
FEEDBACK CONTROL OF THE CELL CYCLE
$535,579Andrew W Murray · Harvard University · R37 · FY2009 · GM
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$535,530Jinming Gao · Ut Southwestern Medical Center · U01 · FY2017 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$535,530Jinming Gao · Ut Southwestern Medical Center · U01 · FY2021 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$535,530Jinming Gao · Ut Southwestern Medical Center · U01 · FY2018 · CA
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
$535,514David B Shackelford · University Of California Los Angeles · R01 · FY2025 · CA
In vivo imaging of mitochondria structure and function in therapy resistant lung tumors
$535,514David B Shackelford · University Of California Los Angeles · R01 · FY2022 · CA
Targeting HER2-low breast cancer with 17p loss
$535,448Xiongbin Lu · Indiana University Indianapolis · R01 · FY2021 · CA
Engineered Nanoformulation for Immune-modulation in Cancer
$535,400Rajagopal Ramesh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · CA
Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma
$535,362J. Silvio Gutkind · University Of California, San Diego · R01 · FY2022 · CA
Project 1: Multi-scale modeling of adaptive drug resistance in BRAF-mutant melanoma
$535,239Peter Karl Sorger · Harvard Medical School · U54 · FY2022 · CA
Elucidating Mechanism of Immune Evasion in Head and Neck Cancers
$535,210Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DE
Systemic RNA Delivery to Tumors
$535,205Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2022 · CA
Glutaredoxin, Glutathione Metabolism and Lung Cancer
$535,116Yvonne M.w. Janssen-Heininger · University Of Vermont & St Agric College · R01 · FY2023 · CA
Novel roles of PCSK9 in regulating the tumor immune microenvironment during radiotherapy
$535,077Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2025 · CA
Novel roles of PCSK9 in regulating the tumor immune microenvironment during radiotherapy
$535,077Chuan-Yuan Li · Duke University · R01 · FY2022 · CA
Targeting the cGAS/STING Pathway to Overcome Resistance to Immune Checkpoint Inhibitors in PTEN-deficient Prostate Cancer
$534,674Akash Patnaik · University Of Chicago · R01 · FY2022 · CA